Avricore Health Inc.

DB:8VP1 Stock Report

Market Cap: €4.1m

Avricore Health Management

Management criteria checks 4/4

Avricore Health's CEO is Hector Bremner, appointed in Oct 2019, has a tenure of 5.17 years. total yearly compensation is CA$321.44K, comprised of 67.2% salary and 32.8% bonuses, including company stock and options. directly owns 1.62% of the company’s shares, worth €65.79K. The average tenure of the management team and the board of directors is 4.5 years and 5.5 years respectively.

Key information

Hector Bremner

Chief executive officer

CA$321.4k

Total compensation

CEO salary percentage67.2%
CEO tenure5.2yrs
CEO ownership1.6%
Management average tenure4.5yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Hector Bremner's remuneration changed compared to Avricore Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CA$103k

Jun 30 2024n/an/a

-CA$3k

Mar 31 2024n/an/a

-CA$341k

Dec 31 2023CA$321kCA$216k

-CA$701k

Sep 30 2023n/an/a

-CA$1m

Jun 30 2023n/an/a

-CA$901k

Mar 31 2023n/an/a

-CA$824k

Dec 31 2022CA$261kCA$168k

-CA$818k

Sep 30 2022n/an/a

-CA$782k

Jun 30 2022n/an/a

-CA$1m

Mar 31 2022n/an/a

-CA$1m

Dec 31 2021CA$258kCA$150k

-CA$2m

Sep 30 2021n/an/a

-CA$2m

Jun 30 2021n/an/a

-CA$2m

Mar 31 2021n/an/a

-CA$2m

Dec 31 2020CA$185kCA$150k

-CA$1m

Sep 30 2020n/an/a

-CA$909k

Jun 30 2020n/an/a

-CA$1m

Mar 31 2020n/an/a

-CA$2m

Dec 31 2019CA$78kCA$76k

-CA$2m

Compensation vs Market: Hector's total compensation ($USD223.68K) is below average for companies of similar size in the German market ($USD469.36K).

Compensation vs Earnings: Hector's compensation has been consistent with company performance over the past year.

CEO

Hector Bremner (42 yo)

5.2yrs

Tenure

CA$321,442

Compensation

Mr. Hector Bremner serves as Chief Executive Officer at Avricore Health Inc. since October 15, 2019 and has been its Director since April 2, 2020. He served as an Executive Vice-President of Branding, Stra...

Leadership Team

NamePositionTenureCompensationOwnership
Hector Bremner
CEO & Director5.2yrsCA$321.44k1.62%
€ 65.8k
Kiriaki Smith
CFO & Corporate Secretary5.3yrsCA$167.95k0.81%
€ 33.1k
Rodger Seccombe
CTO & Director3.7yrsCA$321.44k4.82%
€ 195.8k
Will Seccombe
Communications Advisor3.8yrsno datano data

4.5yrs

Average Tenure

43yo

Average Age

Experienced Management: 8VP1's management team is considered experienced (4.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hector Bremner
CEO & Director4.7yrsCA$321.44k1.62%
€ 65.8k
Rodger Seccombe
CTO & Director4yrsCA$321.44k4.82%
€ 195.8k
David Hall
Independent Chairman of the Board8.9yrsCA$81.43k1.41%
€ 57.3k
Robert Sindelar
Independent Director6.8yrsCA$53.78k0.87%
€ 35.5k
Alan Arnstein
Independent Director7.7yrsCA$53.78k0.025%
€ 1.0k
Sherif Guorgui
Member of Advisory Board5.5yrsno datano data
Philippe Ugnat
Member of Advisory Board5.3yrsno datano data
Ray Chepsiuk
Member of Advisory Board5.9yrsno datano data
Mark Zhou
Member of Advisory Board5.8yrsno datano data
David Huston
Member of Advisory Board5.5yrsno datano data
David Noshad
Member of Advisory Board5.2yrsno datano data
Sotiris Antoniou
Member of Advisory Board5.2yrsno datano data

5.5yrs

Average Tenure

52yo

Average Age

Experienced Board: 8VP1's board of directors are considered experienced (5.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 17:33
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Avricore Health Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution